PERTUZUMAB相关论文
P-MMAE,a novel antibody-drug conjugate,is highly effective against primary HER2 overexpressing gastr
Gastric cancer is one of the most frequent human malignancies and the second leading cause of cancer-related death in th......
分子靶向治疗具有特异性强、效果显著、不良反应小等特点，现已成为人表皮生长因子受体2（HER－2）阳性乳腺癌治疗的重要手段。随着抗 HER－2......
目的:建立一种灵敏度高、特异性好且快速的ELISA方法,用以检测食蟹猴体内的帕妥珠单抗含量。方法:采用双抗夹心的ELISA方法对帕妥......
目的评价对比厄洛替尼、帕妥株单抗单药及联合用药对人非小细胞肺癌、乳腺癌瘤细胞株疗效。方法nu／nu裸鼠90只，分别种植人非小细胞肺......
目的：建立一种灵敏度高、特异性好且快速的ELISA方法,用以检测食蟹猴体内的帕妥珠单抗含量。方法：采用双抗夹心的ELISA方法对帕妥珠......
During the last 15 years we have witnessed an unprecedented expansion in the drugs developed to target human epidermal g......
人表皮生长因子受体2（HER2）为受体酪氨酸激酶家族成员，是多种肿瘤细胞的重要生长调节因子，其过度表达对肿瘤的发生和恶性转化有促进作......
Efficacy,patterns of use and cost of Pertuzumab in the treatment of HER2+metastatic breast cancer in
BACKGROUND Pertuzumab is a humanized anti-human epidermal growth factor receptor 2(HER2)monoclonal antibody found in a P......
<正>1商品名Perjeta2开发与上市厂商本品由瑞士罗氏制药(Hoffmann-La Roche)子公司基因技术公司(Genentech)研制,2012年8月经FDA批......
